Dr Syeda Shamsa Psychiatric Clinic

31/01/2026

04/01/2026

https://www.facebook.com/100050306297601/posts/1468720941481435/

Newly discovered molecule helps repair myelin and restore nerve function in multiple sclerosis

Researchers have identified a small molecule called K102 (with a partner compound K110) that has shown impressive ability to help repair myelin, the protective sheath around nerves, which is damaged in Multiple Sclerosis (MS). Unlike most current therapies that only inhibit immune attacks on the nervous system, K102 helps mature the cells responsible for re-coating nerves (oligodendrocytes) and restores nerve signal speed in animal and human-cell models. K102 also has effects on immune regulation, offering a dual-action approach: remyelination plus immune balancing.

In pre-clinical studies, K102 and K110 were tested in mouse models of MS and in human stem-cell derived oligodendrocytes. K102 emerged as the lead candidate because it promoted myelin repair, improved visual and motor function in mice, and showed good pharmacological properties. The next phase involves further development toward first-in-human trials, making this one of the most advanced regenerative therapy candidates for MS to date.

Although this work is still at the early stage and not yet available for patients, the findings mark a shift in MS treatment strategy: from slowing damage toward enabling repair. If K102 succeeds in clinical testing, it might open the door to restoring function lost from nerve damage rather than just preventing further decline.

Research Paper 📄
DOI: 10.1038/s41598-025-20254-9